MCID: INT075
MIFTS: 45

Intracranial Hypertension malady

Category: Neuronal diseases

Aliases & Classifications for Intracranial Hypertension

About this section

Aliases & Descriptions for Intracranial Hypertension:

Name: Intracranial Hypertension 10 46 47 12 36 65
 
Raised Intracranial Pressure 10

Classifications:



External Ids:

Disease Ontology10 DOID:9428
MeSH36 D019586
NCIt42 C84791
UMLS65 C0151740

Summaries for Intracranial Hypertension

About this section
NINDS:46 Pseudotumor cerebri literally means "false brain tumor." It is likely due to high pressure within the skull caused by the buildup or poor absorption of cerebrospinal fluid (CSF). The disorder is most common in women between the ages of 20 and 50. Symptoms of pseudotumor cerebri, which include headache, nausea, vomiting, and pulsating sounds within the head, closely mimic symptoms of large brain tumors.

MalaCards based summary: Intracranial Hypertension, also known as raised intracranial pressure, is related to cystitis and crohn's disease. An important gene associated with Intracranial Hypertension is OGG1 (8-Oxoguanine DNA Glycosylase), and among its related pathways are LDL Oxidation in Atherogenesis and Bile secretion. The drugs thiopental and urea have been mentioned in the context of this disorder. Affiliated tissues include brain, liver and bone, and related mouse phenotypes are integument and mortality/aging.

Related Diseases for Intracranial Hypertension

About this section

Diseases related to Intracranial Hypertension via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 639)
idRelated DiseaseScoreTop Affiliating Genes
1cystitis30.3CD40LG, CD79A
2crohn's disease30.3F5, TNF
3oral squamous cell carcinoma30.1F2, F5, MTHFR
4urethral calculus30.0AQP4, GFAP, IL1B
5heart disease29.9EPO, F2, IL1B
6meningitis29.7AQP4, IL1B, TNF
7cerebrovascular disease29.7F2, F5, SERPINC1
8meige syndrome29.7CD40LG, IL1B, TNF
9porphyria29.6F2, IL1B, TNF
10ocular hypertension29.5F5, MTHFR, SERPINC1
11adenocarcinoma29.3CD40LG, CD79A, F2, F5, MTHFR, SERPINC1
12asthma29.0CD40LG, CD79A, CYP3A4, IL1B, TNF
13lateral sclerosis28.9AQP1, CD40LG, F2, IL1B, TNF
14myocardial infarction28.8CD40LG, F2, F5, IL1B, MTHFR, SERPINC1
15pseudotumor cerebri12.4
16amelia cleft lip palate hydrocephalus iris coloboma10.5F5, MTHFR
17muller barth menger syndrome10.5F5, MTHFR
18typhus10.5CD40LG, CD79A
19pulmonary edema10.5CD40LG, CD79A
20congenital hypogammaglobulinemia10.5CD40LG, CD79A
21calabro syndrome10.5CD40LG, CD79A
22gamma heavy chain disease10.5CD40LG, CD79A
23azygos continuation of the inferior vena cava10.5F5, MTHFR
24exanthema subitum10.5CD40LG, CD79A
25osteomalacia10.5CD40LG, CD79A
26epidermolysis bullosa simplex10.5CD40LG, CD79A
27proliferative glomerulonephritis10.5CD40LG, CD79A
28cryopyrin-associated periodic syndrome10.5CD40LG, CD79A
29nephrolithiasis10.5AQP4, MTHFR
30craniosynostosis 610.5
31craniosynostosis, type 210.5
32craniosynostosis, type 110.5
33craniosynostosis 310.5
34craniosynostosis 410.5
35tall stature-scoliosis-macrodactyly of the great toes syndrome10.5F2, F5
36acute salpingitis10.5CD40LG, CD79A
37beriberi10.5CD40LG, CD79A
38cavernous sinus thrombosis10.5F5, MTHFR
39purpura10.5CD40LG, CD79A
40choroid plexus meningioma10.4CD40LG, CD79A
41immunotactoid glomerulopathy10.4CD40LG, CD79A
42breast abscess10.4F5, MTHFR
43subacute delirium10.4CD40LG, CD79A
44alpha chain disease10.4CD40LG, CD79A
45internuclear ophthalmoplegia10.4F2, F5
46dysgammaglobulinemia10.4CD40LG, CD79A
47generalized atherosclerosis10.4CD40LG, CD79A
48central sleep apnea10.4CD40LG, CD79A
49sialadenitis10.4CD40LG, CD79A
50ureteral lymphoma10.4CD40LG, CD79A

Graphical network of the top 20 diseases related to Intracranial Hypertension:



Diseases related to intracranial hypertension

Symptoms for Intracranial Hypertension

About this section

Drugs & Therapeutics for Intracranial Hypertension

About this section

Drugs for Intracranial Hypertension (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 213)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Morphineapproved, investigationalPhase 485557-27-25288826
Synonyms:
(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(-)-Heroin hydrochloride
(-)-Morphine
(-)Morphine sulfate
(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol
(5alpha,6alpha)-17-Methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol
(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL
(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol
(−)-morphine
17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol
4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol
4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol
47106-99-0
57-27-2
6211-15-0 (sulfate (2:1) (salt) pentahydrate)
64-31-3
64-31-3 (sulfate (2:1) (salt) anhydrous)
7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol
7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol
8053-16-5
85201-37-2
Apokyn
Astramorph PF
Avinza
BIDD:GT0147
C01516
CCRIS 5762
CHEBI:17303
CHEMBL70
CID5288826
Cube juice
D-(-)-Morphine
DB00295
DEA No. 9300
DepoDur
Depodur
Diacetylmorphine hydrochloride
Diamorphine hydrochloride
Dolcontin
Dreamer
Dulcontin
Duramorph
Duramorph PF
Duromorph
EINECS 200-320-2
Epimorph
HSDB 2134
Hard stuff
Heroin hydrochloride
Heroine hydrochloride
Hocus
Infumorph
 
Kadian
LS-91748
M-Eslon
M.O.S
MOI
MORPHINE SULFATE
MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE
MS Contin
MS/L
MS/S
MSIR
Meconium
MolPort-003-849-273
Morfina
Morfina [Italian]
Morphia
Morphin
Morphin [German]
Morphina
Morphina [Italian]
Morphine
Morphine Extra-Forte
Morphine Forte
Morphine H.P
Morphine Sulfate
Morphine [BAN]
Morphinism
Morphinum
Morphitec
Morphium
Morpho
Moscontin
Ms Contin
Ms Emma
NSC11441
Nepenthe
O,O'-Diacetylmorphine hydrochloride
OMS Concentrate
Oramorph SR
Ospalivina
RMS
RMS Uniserts
Rescudose
Roxanol
Roxanol 100
Roxanol UD
SDZ 202-250
SDZ202-250
Statex
Statex Drops
Statex SR
UNII-76I7G6D29C
Unkie
l-Morphine
morphine
nchembio.317-comp1
nchembio.64-comp1
2
DexmedetomidineapprovedPhase 4, Phase 3, Phase 2470113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
Dexdor (T)
 
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidine Hydrochloride
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex
Precedex (TN)
Tocris-2023
ZINC04632106
3
LabetalolapprovedPhase 4, Phase 3, Phase 23036894-69-63869
Synonyms:
2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide
2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide
2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide
3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
36894-69-6
5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
AB00053659
AC-18747
AC1L1GW8
AH 5158
AH-5158
Albetol
BPBio1_000170
BRD-A07440155-003-05-6
BSPBio_000154
BSPBio_003142
C07063
CHEBI:6343
CHEMBL429
CID3869
D08106
DB00598
DivK1c_000474
EINECS 253-258-3
HSDB 6537
IDI1_000474
Ibidomide
KBio1_000474
KBio2_002087
KBio2_004655
KBio2_007223
KBio3_002642
 
KBioGR_000727
KBioSS_002087
L001344
LS-26936
Labetalol
Labetalol (INN)
Labetalol Hydrochloride
Labetalol [INN:BAN]
Labetalolum
Labetalolum [INN-Latin]
Labetolol
Lopac0_000687
MolPort-003-898-140
NCGC00015595-06
NCGC00089800-02
NINDS_000474
NORMOZIDE
Prestwick0_000277
Prestwick1_000277
Prestwick2_000277
Prestwick3_000277
SBB067266
SPBio_000905
SPBio_002373
Sch-19927
Spectrum2_000863
Spectrum3_001581
Spectrum4_000184
Spectrum5_001010
Spectrum_001607
TL8002725
Trandate
UNII-R5H8897N95
labetalol
4
HydralazineapprovedPhase 4, Phase 24286-54-43637
Synonyms:
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone, hydrazone
1-Hydrazinophthalazine
1-Phthalazinylhydrazine
304-20-1 (mono-hydrochloride)
5-25-17-00412 (Beilstein Handbook Reference)
6-Hydralazine
86-54-4
AC1L1GDN
AC1Q4UY1
AKOS000122609
Apresolin
Apresoline
Apressin
Apressin (pharmaceutical)
Apressoline
Aprezolin
BA 5968
BRD-K82103381-003-03-7
BRN 0132615
BSPBio_002130
C 5968
C-5068
C-5968
C07040
C8H8N4
CAS-304-20-1
CCRIS 5385
CHEBI:5775
CHEMBL276832
CID3637
Ciba 5968
D08044
DB01275
DivK1c_000117
EC-000.1838
EINECS 201-680-3
HLZ
Hidral
Hidral (TN)
Hidralazin
Hidralazina
Hidralazina [INN-Spanish]
Hidralazina [Spanish]
Hipoftalin
Hydralazin
Hydralazine
Hydralazine (INN)
Hydralazine Hydrochloride
Hydralazine [INN:BAN]
 
Hydralazine hydrochloride
Hydralazinum
Hydralazinum [INN-Latin]
Hydrallazin
Hydrallazine
Hydrazinophthalazine
Hydrazone 1(2H)-phthalazinone
Hypophthalin
IDI1_000117
Idralazina
Idralazina [DCIT]
Idralazina [Italian]
InChI=1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)
KBio1_000117
KBio2_001355
KBio2_003923
KBio2_006491
KBio3_001350
KBioGR_000349
KBioSS_001355
LS-109171
Lopac-H-1753
Lopac0_000593
MolPort-000-876-738
MolPort-001-794-088
NCGC00015501-01
NCGC00015501-02
NCGC00015501-05
NCGC00162199-01
NCIOpen2_001484
NINDS_000117
NSC 126699
NSC126699
Oprea1_207681
Oprea1_416878
Phthalazin-1-ylhydrazine
Praparat 5968
Prestwick0_000169
Prestwick1_000169
Prestwick2_000169
SPBio_000977
SPBio_001958
ST50512087
Spectrum2_000969
Spectrum3_000455
Spectrum4_000005
Spectrum5_000822
Spectrum_000875
UNII-26NAK24LS8
WLN: T66 CNNJ BMZ
ZINC12360535
[2H-Phthalazin-(1Z)-Ylidene]-Hydrazine Hydrochloride
hydralazine
phthalazin-1-ylhydrazine
5
RemifentanilapprovedPhase 4409132875-61-760815
Synonyms:
1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester
132539-07-2 (mono-hydrochloride)
132875-61-7
3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic acid methyl ester
4-carboxy-4-(n-phenylpropionamido)-1-piperidinepropionic acid dimethyl ester
AC1L1TZ8
AC1Q5ZGR
BIDD:GT0029
C08021
CHEBI:8802
CHEMBL1005
CID60815
D08473
DB00899
 
DEA No. 9739
GI 87084B
GI 87084X
GI87084B
L001266
LS-115982
MolPort-004-286-006
REMIFENTANIL
Remifentanil (INN)
Remifentanil [INN:BAN]
Remifentanyl
UNII-P10582JYYK
Ultiva
Ultiva (TN)
methyl 1-(3-methoxy-3-oxopropyl)-4-(N-propanoylanilino)piperidine-4-carboxylate
6
ClevidipineapprovedPhase 4, Phase 3, Phase 220166432-28-6
Synonyms:
 
Clevidipine butyrate
Cleviprex
7
EsmololapprovedPhase 4, Phase 3, Phase 148103598-03-459768
Synonyms:
(+-)-Esmolol
(+-)-Methyl P-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
(+-)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
103598-03-4
3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester
81147-92-4
81161-17-3 (Hydrochloride)
84057-94-3
AC-12058
AC1L1RWQ
AC1Q5ZXA
ASL 8052-001
BRN 5287174
Benzenepropanoic acid, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-, methyl ester
Brevibloc
C06980
CHEBI:4856
CHEMBL768
CID59768
 
D07916
DB00187
ESMOLOL
Esmolol
Esmolol (INN)
Esmolol Hydrochloride
Esmolol [INN:BAN]
HMS2090P06
L001332
LS-185019
LS-31121
Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate
Methyl P-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
MolPort-005-933-593
UNII-MDY902UXSR
methyl 3-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]propanoate
methyl 3-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]propanoate
methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate
methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate
methyl p-[2-hydroxy-3-(isopropylamino)propoxy]hydrocinnamate
8
CosyntropinapprovedPhase 42416960-16-016129617
Synonyms:
16960-16-0
ATCH (1-24)
Adrenocorticotropic hormone 1-24
COSYNTROPIN
Corticotropin-(1-24)
Corticotropin-(1-24) tetracosapeptide
Cortrosyn
Cortrosyn (TN)
 
Cosyntropin
Cosyntropin (USAN)
D00284
SYSMEHFRWGKPVGKKRRPVKVYP
SerTyrSerMetGluHisPheArgTrpGlyLysProValGlyLysLysArgArgProValLysValTyrPro
Tetracosactide
Tetracosactide (INN)
alpha(1-24)-Corticotrophin
beta(1-24)-Corticotrophin
9
Mannitolapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 124269-65-8453, 6251
Synonyms:
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexaol
(2R,3R,4R,5R)-Hexane-1,2,3,4,5,6-hexol
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
(L)-Mannitol
1,2,3,4,5,6-Hexanehexol
123897-58-5
133-43-7
15719_ALDRICH
15719_RIEDEL
33440_RIEDEL
33440_SIGMA
36413-61-3
4-01-00-02841 (Beilstein Handbook Reference)
5149-40-6
63559_FLUKA
63559_SIGMA
63560_FLUKA
63565_FLUKA
63565_SIGMA
69-65-8
75398-80-0
85085-15-0
87-78-5
AB1002081
AC-12776
AC1L1M49
AC1Q28E5
AI3-19511
AR-1J3861
Ambap69-65-8
BRN 1721898
C00392
C6H14O6
CCRIS 369
CHEBI:16899
CHEMBL689
CID6251
Cordycepate
Cordycepic acid
D-(-)-Mannitol
D-Mannitol
D-Mannitol (JP15)
D-mannite
D-mannitol
D00062
D008353
DL-Mannitol
Diosmol
ED1D1E61-FEFB-430A-AFDC-D1F4A957FC3D
EINECS 200-711-8
EINECS 201-770-2
Fraxinine
HSDB 714
Hexahydroxyhexane
Hexanhexol
Invenex
Isotol
LS-1588
LS-89250
M0044
M1902_SIGMA
M4125_SIAL
M8429_SIAL
M9546_SIAL
M9647_SIAL
MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER
MANNITOL 15% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.45%
 
MANNITOL 25%
MANNITOL 5% W/ DEXTROSE 5% IN SODIUM CHLORIDE 0.12%
MLS001335977
MLS001335978
MTL
Manicol
Manitol
Maniton S
Maniton-S
Manna Sugar
Manna sugar
Mannazucker
Mannidex
Mannidex 16700
Mannigen
Mannistol
Mannit
Mannit p
Mannite
Mannitol
Mannitol (USP)
Mannitol (VAN)
Mannitol 10%
Mannitol 10% In Plastic Container
Mannitol 15%
Mannitol 15% In Plastic Container
Mannitol 20%
Mannitol 20% In Plastic Container
Mannitol 5%
Mannitol 5% In Plastic Container
Mannitol [USAN]
Mannitolum
Mannogem 2080
Marine Crystal
Marine crystal
MolPort-003-927-039
Mushroom sugar
NCGC00164246-01
NCI-C50362
NSC 407017
NSC 9256
OSMITROL 10% IN WATER IN PLASTIC CONTAINER
OSMITROL 15% IN WATER IN PLASTIC CONTAINER
OSMITROL 20% IN WATER IN PLASTIC CONTAINER
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
Osmitrol
Osmitrol (TN)
Osmitrol 10% In Water
Osmitrol 15% In Water
Osmitrol 20% In Water
Osmitrol 5% In Water
Osmofundin
Osmosal
Resectisol
Resectisol In Plastic Container
SDM No. 35
SMR000857324
SORBITOL-MANNITOL IN PLASTIC CONTAINER
Sorbitol-Mannitol
TL806434
UNII-3OWL53L36A
ZINC02041302
bmse000099
cpd without stereochemical designation
e 421
e-421
e421
manita
mannitol
10
NicardipineapprovedPhase 4, Phase 3, Phase 12955985-32-54474
Synonyms:
2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester
3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-,2-(benzylmethylamino)ethyl methyl ester
5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
55985-32-5
AB00514658
AC-19947
AC1L1I8Y
AKOS001637090
Ambap55985-32-5
BIDD:GT0621
BPBio1_000623
BRD-A26711594-001-02-7
BRD-A26711594-003-05-6
BRN 0504321
BSPBio_000565
BSPBio_001389
BSPBio_002943
Bio1_000088
Bio1_000577
Bio1_001066
Bio2_000109
Bio2_000589
C07264
C26H29N3O6
CBiol_001802
CHEBI:507549
CHEMBL1484
CID4474
Cardene
Cardene (TN)
Cardene IV
Cardene Iv
Cardene SR
D08270
DB00622
DivK1c_000540
EINECS 259-932-3
HMS1791F11
HMS1989F11
HMS2089C09
IDI1_000540
IDI1_033859
KBio1_000540
 
KBio2_000109
KBio2_001852
KBio2_002677
KBio2_004420
KBio2_005245
KBio2_006988
KBio3_000217
KBio3_000218
KBio3_002443
KBioGR_000109
KBioGR_000744
KBioSS_000109
KBioSS_001852
L000715
LS-131263
Lopac0_000809
MolPort-002-484-049
NCGC00015747-06
NCGC00162262-01
NCGC00162262-02
NCGC00162262-03
NCGC00162262-04
NINDS_000540
Nicardipine (INN)
Nicardipine Hydrochloride
Nicardipine LA
Nicardipine [INN:BAN]
Nicardipino
Nicardipino [INN-Spanish]
Nicardipinum
Nicardipinum [INN-Latin]
Oprea1_436998
Prestwick0_000383
Prestwick1_000383
Prestwick2_000383
Prestwick3_000383
SPBio_001490
SPBio_002486
Spectrum2_001415
Spectrum3_001452
Spectrum4_000422
Spectrum5_001320
Spectrum_001372
UNII-CZ5312222S
Y-93
methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
nicardipine
11
AspirinapprovedPhase 4, Phase 2, Phase 3102950-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
7 Select Adult Chewable Aspirin
7 Select Aspirin
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Adult Chewable Low Dose Aspirin
Adult Low Dose Aspirin
Adult Low Dose Aspirin Enteric Safety Coated
Adult Low Dose Enteric Coated Aspirin
Adult Low Strength Aspirin
Aloxiprimum
Asacard
Asagran
Asaphen
Asatard
Ascoden-30
Ascriptin Maximum Strength Buffered Aspirin
Ascriptin Regular Strength Buffered Aspirin
Aspalon
Aspec
Aspergum
Aspi-cor
Aspir Low
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin 81 Mg
Aspirin 81 Mg Low Dose
Aspirin Adult Low Dose
Aspirin Adult Low Strength
Aspirin Adult Low Strength Aspirin
Aspirin Adult low strength
Aspirin Chewable Low Dose
Aspirin Delayed Release
Aspirin EC
Aspirin EXTRA STRENGTH
Aspirin Ec
Aspirin Enteric
Aspirin Enteric Coated
Aspirin Enteric Coated Low Dose
Aspirin Enteric Safety Coated
Aspirin Enteric Safety-Coated
Aspirin Low Dose
Aspirin Low Dose Chewable
Aspirin Low Dose Enteric Coated
Aspirin Low Dose Safety Coated
Aspirin Low Strength
Aspirin Nsaid
Aspirin Regular Strength
Aspirin Regular Strength regular strength
Aspirin Regular strength
Aspirin Safety Coated
Aspirin Safety Coated Adult Low Dose
Aspirin Safety coated
Aspirin Thin coated
Aspirin [BAN:JAN]
Aspirin adult low dose
Aspirin adult low strength
Aspirin enteric safety coated
Aspirin low dose
Aspirin low dose chewable
Aspirin low dose enteric coated
Aspirin regular strength
Aspirina 03
Aspirine
Aspiring
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Advanced Aspirin Extra Strength
Bayer Advanced Aspirin Regular Strength
Bayer Aspirin 8 Hour
Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange
Bayer Aspirin Regimen Regular Strength
Bayer Buffered
Bayer Chewable - Aspirin Regimen Low Dose Aspirin Cherry Flavored
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Fast Release
Bayer Genuine Aspirin
Bayer Low Dose
Bayer Plus
Bayer Plus Extra Strength
Bayer Womens
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Buffered Aspirin
Bufferin
Bufferin LOW DOSE BUFFERED ASPIRIN
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Care One Aspirin
Cemirit
Chewable Adult Low Dose Aspirin
Chewable Aspirin
Chewable Low Dose Aspirin
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Critical Care Aspirin To Go
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dg Health Aspirin
Direct Safety Aspirin
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ec-81aspirin Enteric Coated
Ecolen
Ecotrin
Ecotrin Regular Strength
Empirin
Empirin with Codeine
Endosprin
Endydol
Enteric Aspirin
Enteric Coated Aspirin
Enteric Coated Aspirin Regular Strength
Enteric Coated Aspirin Regular strength
Enteric Coated Aspirin regular strength
Enteric Coated Asprin 81 Mg
Enteric Coated Low Dose Aspirin
 
Enteric Safety Coated Aspirin
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Equaline Aspirin
Equaline Aspirin adult low dose
Equate Aspirin
Equate Aspirin chewable
Extren
Fasprin
Flanax Aspirin Pain Reliever
Formucare Aspirin
Genuine Aspirin
Globentyl
Globoid
Good Neighbor Pharmacy Aspirin
Good Neighbor Pharmacy Aspirin Enteric Safety Coated
Good Neighbor Pharmacy Aspirin orange flavor chewable
Good Sense Aspirin
Good Sense Aspirin Enteric Safety Coated
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Handy Solutions Genuine Aspirin Bayer
Health Mart Aspirin
Health Mart Regular Strength Enteric Coated Aspirin
Health Sense Adult Chewable Low Strength Aspirin
Health Sense Aspirin 81
Health Sense Ecpirin
Healthy Accents Aspirin
Helicon
Henry Schein Aspirin
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kroger Value Aspirin
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Leader Aspirin
Leader Cardinal Health Aspirin
Leader Low Dose Aspirin
Levius
Lopac-A-5376
Lopac0_000038
Low Dose Adult Aspirin
Low Dose Aspirin
Low Dose Aspirin 81 Mg Safety Coated
Low Dose Aspirin Enteric Safety Coated
Low Dose Asprin
Low Dose Chewable Aspirin
Low Dose Miniprin Enteric Safety Coated
Low Dose Pain Relief Aspirin
Low Strength Chewable Aspirin
Low-dose Aspirin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medi First Plus Aspirin
Medi-first Aspirin
Medique Aspirin
Medisyl
Micristin
Micro-coated Aspirin
Miniprin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
North Aspirin
Novasen
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Pain Relief Aspirin
Pain Relief Aspirin Low Dose
Persistin
Pharbest Aspirin 325mg
Pharbest Regular Strength Aspirin
Pharmacin
Pirseal
Plus Pharma NSAID 325 mg
Plus Pharma Nsaid Aspirin
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rapid Comfort Aspirin
Regular Strength Aspirin
Regular Strength Aspirin Ec
Regular Strength Buffered Aspirin
Regular Strength Enteric Aspirin
Regular Strength Enteric Coated Aspirin
Regular Strength Pain Relief
Regular Strength Tri-buffered Aspirin
Rexall Aspirin
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
Rugby Aspirin
Rx Act Aspirin
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Safety Coated Aspirin
Safety Coated Enteric Aspirin
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Smart Health Aspirin regular strength
Smart Sense Aspirin
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Solves - Aspirin Cherry
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
St. Joseph Chewable Aspirin
St. Joseph Safety Coated Aspirin
Sunmark Aspirin
Sunmark Aspirin Regular Strength
Sunmark Aspirin adult low strength
Sunmark Aspirin low dose
Supac
Tasprin
Temperal
Toldex
Topcare Aspirin
Tri-buffered Aspirin
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Uncoated Aspirin
Value Pharma Aspirin Pain Reliever
Value Pharmapain Reliever Extra Strength
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
Zee Aspirin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
12
Minocyclineapproved, investigationalPhase 417310118-90-85281021
Synonyms:
(2Z,4S,4aS,5aR,12aS)-2-[amino(hydroxy)methylidene]-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AS,5AR,12AS)-4,7-BIS(DIMETHYLAMINO)-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-1,4,4A,5,5A,6,11,12A-OCTAHYDROTETRACENE-2-CARBOXAMIDE
(4S,4AS,5ar,12as)-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10118-90-8
13614-98-7 (mono-hydrochloride)
4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide
4708-96-7
7-Dimethylamino-6-demethyl-6-deoxytetracycline
AC1NQXWM
Arestin
BRN 3077644
Bio-0062
Borymycin
C07225
C23H27N3O7
CHEBI:50694
CHEBI:529981
CHEMBL1434
CHEMBL259172
CID5281021
CL 59806
CRL-1605 & Minocycline
D05045
Dynacin
HMS2090D03
HSDB 3130
LMPK07000002
 
LS-93850
Lactoferrin B & Minocycline
Lactoferrin H & Minocycline
MINO
MIY
Minociclina
Minociclina [INN-Spanish]
Minociclinum
Minocin
Minocin (Hydrochloride)
Minocline
Minocyclin
Minocycline
Minocycline (USAN/INN)
Minocycline Hydrochloride
Minocycline Monohydrochloride
Minocycline [USAN:BAN:INN]
Minocyclinum
Minocyclinum [INN-Latin]
NCGC00178854-01
NSC 141993
NSC141993
Solodyn
UNII-FYY3R43WGO
Vectrin (Hydrochloride)
Ximino
minociclinum
minocycline
nchembio.559-comp1
13
AtracuriumapprovedPhase 46564228-79-147319
Synonyms:
1-[(3,4-Dimethoxyphenyl)methyl]-2-[3-({5-[(3-{1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl}propanoyl)oxy]pentyl}oxy)-3-oxopropyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium]
5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl 3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate
64228-79-1
64228-81-5 (besylate)
AB00514743
AC1L2HUF
AC1Q67HR
ATRACURIUM
Atracurium
Atracurium Dibesylate
BPBio1_000011
BRN 1523633
 
BSPBio_000009
C07548
C53H70N2O12
CHEBI:2914
CHEMBL1360
CID47319
DB00732
HMS2090I21
LS-86151
MolPort-005-932-641
Prestwick1_000005
Prestwick2_000005
Prestwick3_000005
SPBio_001930
UNII-2GQ1IRY63P
14
LymecyclineapprovedPhase 44992-21-25280963, 24757945
Synonyms:
(+)-N-(5-Amino-5-carboxypentylaminomethyl)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide
7-Chlorotetracycline
992-21-2
Acronize PD
Aureociclin
Aureomicina
Aurofac
Aurofac 10
Biovetin
CHEBI:59040
CLTC
Centraureo
Chlorotetracycline
Chlortetracyclin
 
Chlortetracycline
Chlortetracyclinium chloride
Chrusomykine
D06884
DB00256
Limeciclina
Lymecycline (INN)
Lymecyclinum
N(2)-(((+)-5-Amino-5-carboxypentylamino)methyl)tetracycline
N(6)-[({[(4S,4aS,5aS,6S,12aS)-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracen-2-yl]carbonyl}amino)methyl]-L-lysine
N-Lysinomethyltetracycline
N6-((4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamido)methyl)lysine
Orospray
Tetracycline-L-methylene lysine
Tetracycline-L-methylenelysine
Tetrlysal 300
15
IsotretinoinapprovedPhase 41154759-48-25538, 5282379
Synonyms:
(13-cis)-Retinoate
(13-cis)-Retinoic acid
(13cis)-retinoic acid
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
(2Z,4E6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid
(7E,9E,11E,13Z)-retinoic acid
(7e,9e,11e,13Z)-Retinoic acid
13 Cis-Retinoic Acid
13 cis retinoic acid
13-RA
13-cis RA
13-cis retinoic acid
13-cis-Retinoate
13-cis-Retinoic acid
13-cis-Vitamin A acid
13-cis-Vitamin a acid
3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)2-cis-4-trans-6-trans-8-trans-nonatetraenoic acid
4-09-00-02388 (Beilstein Handbook Reference)
4759-48-2
97950-17-9
AC-15388
AC1NQZZ4
Absorica
Accutane
Accutane (TN)
Ambap302-79-4
Amnesteem
BML2-E07
BPBio1_000080
BRD-K76723084-001-05-9
BRN 1885770
BSPBio_000072
BSPBio_001331
BSPBio_003345
CCRIS 4286
CHEBI:6067
CHEMBL547
CID5282379
CIP-Isotretinoin
CPD000471891
Claravis
Clarus
D00348
D015474
EINECS 225-296-0
EU-0101081
Epuris
HMS1361C13
HMS1568D14
HMS1791C13
HMS1921D08
HMS1989C13
HMS2092N07
HSDB 3929
IDI1_033801
Isotane
Isotretinoin
Isotretinoin (USP)
 
Isotretinoin Retinoic acid
Isotretinoin Zinc Salt, 13 cis Isomer
Isotretinoin Zinc Salt, 13-cis-Isomer
Isotretinoin [USAN:BAN:INN]
Isotretinoin [USAN:INN:BAN]
Isotretinoina
Isotretinoine
Isotretinoine [INN-French]
Isotretinoino
Isotretinoino [INN-Spanish]
Isotretinoinum
Isotretinoinum [INN-Latin]
Isotrex
LMPR01090021
LS-143465
Lopac0_001081
MLS001074662
MolPort-003-666-394
Myorisan
NCGC00094358-01
NCGC00094358-02
NCGC00094358-03
NCGC00094358-04
NCGC00094358-05
NCGC00094358-06
NCGC00094358-07
NCGC00094358-08
NCGC00094358-09
NCGC00094358-13
Neovitamin A acid
Neovitamin a acid
Prestwick2_000256
Prestwick3_000256
Prestwick_642
R 3255
R3255_SIGMA
Retinoate
Retinoic acid
Ro 4 3780
Ro 4-3780
Ro 43780
Ro-4-3780
Ro-43780
Roaccutan
Roaccutane
Roacutan
SAM002548955
SMR000471891
SPECTRUM1502013
Sotret
Sotret (TN)
Spectrum5_001795
Spectrum5_001937
Teriosal
UNII-EH28UP18IF
Zenatane
cis-RA
cis-Retinoate
cis-Retinoic acid
isotretinoino
16
Doxycyclineapproved, investigationalPhase 4219564-25-054671203, 5281011
Synonyms:
(2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione
(4S,4AR,5S,5ar,6R,12as)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
(4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
10597-92-9
17086-28-1 (mono-hydrate)
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)
24390-14-5
41411-66-9 (6-epimer, mono-hydrochloride)
5-Hydroxy-alpha-6-deoxytetracycline
564-25-0
6-Deoxyoxytetracycline
6-Deoxytetracycline
6-alpha-Deoxy-5-oxytetracycline
6-alpha-deoxy-5-oxytetracycline
69935-17-7 (mono-hydrochloride, di-hydrate)
6alpha-Deoxy-5-oxytetracycline
6α-deoxy-5-oxytetracycline
7164-70-7
7264-10-0
94088-85-4 (calcium salt (1:2))
AB08 (*Fosfatex)
AC1NQXW7
AC1NS4CW
AC1NUYS8
AC1O8PYM
Adoxa
Alodox
Alti-Doxycycline
Apo-Doxy
Atridox
Azudoxat
BCBcMAP01_000024
BIDD:GT0146
BMY-28689
BPBio1_000951
BSPBio_000863
BSPBio_001936
BU-3839T
C06973
CHEBI:50845
CHEMBL1433
CID5281011
CID5353597
CID5463943
CID6713981
CPD001550033
D07876
DB00254
DMSC (*Fosfatex)
DOXCYCLINE ANHYDROUS
DOXY
DOXYCYCLINE CALCIUM
DOXYCYCLINE MONOHYDRATE
Deoxymykoin
DivK1c_000345
Doryx
Dossiciclina
Dossiciclina [DCIT]
Doxcycline anhydrous
Doxiciclina
Doxiciclina [INN-Spanish]
Doxiciclina [Italian]
Doxitard
Doxivetin
Doxy 100
Doxy-Caps
Doxy-Puren
Doxy-Tabs
Doxycen
Doxychel
Doxychel (TN)
Doxycin
Doxycyclin
Doxycycline
Doxycycline (200mg/day) or Placebo
Doxycycline (INN)
 
Doxycycline (TN)
Doxycycline (anhydrous)
Doxycycline (internal use)
Doxycycline Hyclate
Doxycycline Monohydrate
Doxycycline anhydrous
Doxycycline hyclate
Doxycycline hydrochloride
Doxycycline-Chinoin
Doxycyclinum
Doxycyclinum [INN-Latin]
Doxysol
Doxytec
Doxytetracycline
EINECS 209-271-1
GS-3065 (*monohydrate)
HMS2090E06
HSDB 3071
Hydramycin
IDI1_000345
Investin
Jenacyclin
KBio1_000345
KBio2_001287
KBio2_003855
KBio2_006423
KBio3_001156
KBioGR_001133
KBioSS_001287
LS-187766
LS-93868
Liviatin
Lopac0_000405
MolPort-002-507-423
Monodox
Monodox (*monohydrate)
Morgidox
NCGC00161602-01
NCGC00161602-03
NCGC00161602-04
NCGC00167961-01
NCGC00179395-01
NINDS_000345
NSC633557
Novo-Doxylin
Nu-Doxycycline
Ocudox
Oracea
Prestwick0_000852
Prestwick1_000852
Prestwick2_000852
Prestwick3_000852
Ronaxan
SAM002589932
SMP1_000107
SPBio_000246
SPBio_002784
STOCK1N-34341
Spanor
Spectrum2_000143
Spectrum3_000408
Spectrum4_000527
Spectrum5_000947
Spectrum_000807
Supracyclin
UNII-334895S862
UPCMLD-DP021
UPCMLD-DP021:001
Vibra-tabs
Vibramycin
Vibramycin (*monohydrate)
Vibramycin Monohydrate
Vibramycin Novum
Vibramycine
Vibravenos
Vivox (*Hyclate)
alpha-6-Deoxy-5-hydroxytetracycline
alpha-6-Deoxyoxytetracycline
alpha-Doxycycline
doxycycline
17
Clopidogrelapproved, nutraceuticalPhase 4, Phase 3, Phase 2717120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel Bisulfate
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
 
IDI1_000787
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
18parecoxibexperimentalPhase 439119828
19
butyric acidexperimentalPhase 4, Phase 2292107-92-6264
Synonyms:
1-Butanoate
1-Butanoic acid
1-Butyrate
1-Butyric acid
1-Propanecarboxylate
1-Propanecarboxylic acid
Butanate
Butanic acid
Butanoate
Butanoic acid
Buttersaeure
Butyrate
 
Butyric acid
Ethylacetate
Ethylacetic acid
Honey robber
Kyselina maselna
N-Butanoate
N-Butanoic acid
N-Butyrate
N-Butyric acid
Propanecarboxylate
Propanecarboxylic acid
Propylformate
Propylformic acid
20Adrenergic AgonistsPhase 4, Phase 3, Phase 2, Phase 12331
21Adrenergic alpha-2 Receptor AgonistsPhase 4, Phase 3, Phase 2790
22Adrenergic alpha-AgonistsPhase 4, Phase 3, Phase 2, Phase 11300
23Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 14204
24Adrenergic AntagonistsPhase 4, Phase 3, Phase 2, Phase 11253
25Central Nervous System DepressantsPhase 4, Phase 3, Phase 2, Phase 110016
26Cyclooxygenase InhibitorsPhase 4, Phase 2, Phase 32225
27Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 29988
28Hormone AntagonistsPhase 4, Phase 3, Phase 210002
29HormonesPhase 4, Phase 3, Phase 211748
30Pharmaceutical SolutionsPhase 4, Phase 2, Phase 3, Phase 17004
31Natriuretic AgentsPhase 4, Phase 2, Phase 3, Phase 11403
32(1-6)-alpha-glucomannanPhase 414
33AnestheticsPhase 4, Phase 2, Phase 3, Phase 17385
34Vasodilator AgentsPhase 4, Phase 3, Phase 2, Phase 12926
35diureticsPhase 4, Phase 2, Phase 3, Phase 11194
36Antirheumatic AgentsPhase 4, Phase 2, Phase 38496
37Cyclooxygenase 2 InhibitorsPhase 4538
38Peripheral Nervous System AgentsPhase 4, Phase 2, Phase 3, Phase 118510
39Anesthetics, GeneralPhase 4, Phase 3, Phase 22274
40Anti-Inflammatory Agents, Non-SteroidalPhase 4, Phase 2, Phase 33549
41Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 114795
42NarcoticsPhase 4, Phase 22709
43Anesthetics, IntravenousPhase 4, Phase 3, Phase 21943
44Hypnotics and SedativesPhase 4, Phase 3, Phase 22032
45Analgesics, OpioidPhase 4, Phase 22304
46Antihypertensive AgentsPhase 4, Phase 3, Phase 2, Phase 13618
47Adrenergic beta-1 Receptor AntagonistsPhase 4, Phase 3, Phase 1292
48Analgesics, Non-NarcoticPhase 4, Phase 2, Phase 35184
49Anti-Inflammatory AgentsPhase 4, Phase 2, Phase 38478
50calcium channel blockersPhase 4, Phase 3, Phase 2, Phase 11743

Interventional clinical trials:

(show top 50)    (show all 183)
idNameStatusNCT IDPhase
1Mannitol Versus Hypertonic Saline Solution in the Treatment of Elevated Intracranial PressureCompletedNCT00447018Phase 4
2Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After CraniotomyCompletedNCT02037815Phase 4
3A Post Marketing Surveillance Study for NutropinAq® in Adults With Growth Hormone DeficiencyCompletedNCT00455884Phase 4
4Mannitol Improves Cerebral Oxygen SaturationCompletedNCT02091180Phase 4
5Cosyntropin Versus Epidural Blood Patch (EBP) for Treatment of Treatment of Post Dural Puncture HeadacheCompletedNCT02394457Phase 4
6A Comparison of the Perioperative Hemodynamic Effects of Remifentanil and Esmolol in Intracranial SurgeryCompletedNCT01628562Phase 4
7A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical PatientsCompletedNCT00952081Phase 4
8Effect of Parecoxib on Post-craniotomy PainCompletedNCT00455117Phase 4
9Comparison of Dexmedetomidin and Remifentanil for the Effect on Airway Reflex and Hemodynamic Response During Emergence in Patients Undergoing CraniotomyCompletedNCT01365923Phase 4
10Treatment of Intracranial Hypertension of Severe Tramatic Brain Injured Patients. Physiopathologic Effects of Neuromuscular Blocking AgentsRecruitingNCT02404779Phase 4
11Antiacne Medications Pseudotumor CerebriRecruitingNCT02149615Phase 4
12Comparison of 20% Mannitol and 3% Hypertonic Saline for Cerebral Relaxation During Elective Supratentorial CraniotomiesRecruitingNCT01745081Phase 4
13The Efficacy and Safety of Cleviprex in Ventriculostomy Patients Requiring IV Antihypertensive TherapyRecruitingNCT01042574Phase 4
14Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis in ChinaRecruitingNCT01968122Phase 4
15IV Double and Triple Concentrated Nicardipine for Stroke and ICHRecruitingNCT00325793Phase 4
16Comparison of 2 Doses of Mannitol on Post Traumatic Intracranial Hypertension and Cerebral MonitoringTerminatedNCT00795587Phase 4
17Cerebral Hemodynamic Effects of Hypertonic Solutions in Severely Head-Injured PatientsTerminatedNCT00125229Phase 4
18Effect of Intrathoracic Pressure Regulation on Traumatic Brain InjuryTerminatedNCT01824589Phase 4
19ShuntCheck Accuracy in Detecting Shunt Obstruction Normal Pressure Hydrocephalus (NPH) PatientsWithdrawnNCT00793416Phase 4
20Comparison of Allogenix Plus Demineralized Bone Matrix and Autogenous Bone Dust Versus Autogenous Bone Dust Alone in Ossification of Small Calvarial Defects, a Pilot Study.WithdrawnNCT01006148Phase 4
21The Effect of Clevidipine on Intracranial Pressure and Cerebral Perfusion Pressure (CCP) in Brain Injured PatientsWithdrawnNCT01526876Phase 4
22The Evaluation of Clevidipine in Patients Requiring ICP Monitoring and IV Antihypertensive TherapyWithdrawnNCT01910532Phase 4
23Idiopathic Intracranial Hypertension Treatment TrialCompletedNCT01003639Phase 2, Phase 3
24Preventive Sodium Lactate and Traumatic Brain InjuryCompletedNCT00995683Phase 2, Phase 3
25Impact of Ventricular Catheter Used With Antimicrobial Agents on Patients With a Ventricular CatheterCompletedNCT00286104Phase 3
26Anti-Oxidant Supplementation for the Prevention of Acute Mountain SicknessCompletedNCT00664001Phase 3
27Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)CompletedNCT00666328Phase 3
28Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial StenosisCompletedNCT00576693Phase 3
29Antihypertensive Treatment of Acute Cerebral Hemorrhage-IICompletedNCT01176565Phase 3
30Clinical Value of Noninvasive Intracranial Pressure MeasurementRecruitingNCT02130219Phase 2, Phase 3
31Esmolol Versus Dexmedetomidine During Intracranial ProceduresRecruitingNCT02563288Phase 3
32Randomized Trial of Erythropoietin During Cerebral MalariaRecruitingNCT00697164Phase 2, Phase 3
33Normal Pressure Hydrocephalus Treatment by AcetazolamideRecruitingNCT02163330Phase 3
34Efficacy Study of Hypothermia Plus Magnesium Sulphate(MgSO4) in the Management of Term and Near Term Babies With Hypoxic Ischemic EncephalopathyRecruitingNCT01646619Phase 3
35The DECRA Trial: Early Decompressive Craniectomy in Patients With Severe Traumatic Brain InjuryActive, not recruitingNCT00155987Phase 3
36Mannitol as Adjunct Therapy for Childhood Cerebral MalariaActive, not recruitingNCT00113854Phase 3
37Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004Active, not recruitingNCT00426101Phase 3
38Comparison of Effectiveness of Pentobarbital and Thiopental in Patients With Refractory Intracranial HypertensionTerminatedNCT00622570Phase 3
39Mannitol vs HS to Treat ICHT After Severe TBI : Comparison on PtiO2 and Microdialysis ValuesTerminatedNCT01028339Phase 3
40Sodium-Lactate and Traumatic Brain InjuryTerminatedNCT00319345Phase 2, Phase 3
41Hypertonic Saline vs. Mannitol for Elevated Intercranial PressureTerminatedNCT01111682Phase 3
42Hypothermia in Children After TraumaTerminatedNCT00222742Phase 3
43Clinical Trial of Growth Hormone in MPS I, II, and VITerminatedNCT00748969Phase 2, Phase 3
44Induced Hypertension for Treatment of Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid HaemorrhageTerminatedNCT01613235Phase 3
45Induced Hypertension for Delayed Cerebral Ischaemia After Aneurysmal Subarachnoid Haemorrhage:a Feasibility StudyTerminatedNCT00841633Phase 3
46HyperHAES Versus Placebo - Effect on Intracranial Pressure in SAH PatientsCompletedNCT00199706Phase 2
47Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)CompletedNCT00974259Phase 2
48Dexamethasone in Cryptococcal MeningitisCompletedNCT00000776Phase 2
49Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic StrokeCompletedNCT01428401Phase 2
50Effects of Saline on Circulation in ChildrenCompletedNCT01668277Phase 2

Search NIH Clinical Center for Intracranial Hypertension

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: intracranial hypertension

Genetic Tests for Intracranial Hypertension

About this section

Anatomical Context for Intracranial Hypertension

About this section

MalaCards organs/tissues related to Intracranial Hypertension:

33
Brain, Liver, Bone, Endothelial, Breast, Kidney, Heart

Animal Models for Intracranial Hypertension or affiliated genes

About this section

MGI Mouse Phenotypes related to Intracranial Hypertension:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00107717.5CD40LG, EPO, F2, F5, HSD11B1, IL1B
2MP:00107686.3AQP1, AQP4, CD40LG, EPO, F2, F5
3MP:00053876.1AQP4, CD40LG, CD79A, F2, GFAP, HSD11B1
4MP:00053975.9AQP1, AQP4, CD40LG, CD79A, EPO, F2
5MP:00036315.8AQP1, AQP4, CD40LG, CD79A, F2, F5
6MP:00053855.7AQP1, AQP4, CD40LG, EPO, F2, F5
7MP:00053765.0AQP1, AQP4, CD40LG, CD79A, EPO, F2

Publications for Intracranial Hypertension

About this section

Articles related to Intracranial Hypertension:

(show top 50)    (show all 706)
idTitleAuthorsYear
1
Strokes in Sneddon syndrome without antiphospholipid antibodies. (25628239)
2015
2
Novel Compound Heterozygous CBS Mutations Cause Homocystinuria in a Han Chinese Family. (26667307)
2015
3
Integrin I+vI^6 sustains and promotes tumor invasive growth in colon cancer progression. (26139991)
2015
4
Quantitative proteomic profiling of human articular cartilage degradation in osteoarthritis. (25383958)
2014
5
Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening. (25367852)
2014
6
Urinary interleukin-8 is a biomarker of stress in emergency physicians, especially with advancing age--the JOBSTRESS* randomized trial. (23977105)
2013
7
When you can have the bird without shooting it!: Extramacular enhanced depth optical coherence tomography in birdshot chorioretinopathy. (24114135)
2013
8
Facial nerve palsy and hemifacial spasm. (23931790)
2013
9
Association of genetic variation in CACNA1C with bipolar disorder in Han Chinese. (23680436)
2013
10
Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model. (24388358)
2013
11
The Angelman syndrome protein Ube3a is required for polarized dendrite morphogenesis in pyramidal neurons. (23283345)
2013
12
Evaluation of the measurement of the middle cerebral artery peak systolic velocity before and after placental laser coagulation in twin-to-twin transfusion syndrome. (22418955)
2012
13
Association of vitamin D receptor gene polymorphisms with insulin resistance and response to vitamin D. (21871642)
2012
14
Wnt1 inducible signaling pathway protein 1 (WISP1) targets PRAS40 to govern I^-amyloid apoptotic injury of microglia. (22873724)
2012
15
The value of F-18 FDG PET in patients with primary sclerosing cholangitis and cholangiocarcinoma using visual and semiquantitative analysis. (21892037)
2011
16
Association between vitamin B12 levels and mortality in hospitalized older adults. (20158555)
2010
17
Elevated serum advanced glycation end products and their circulating receptors are associated with anaemia in older community-dwelling women. (19252206)
2009
18
Spectroscopic investigations of the binding interaction of a new indanedione derivative with human and bovine serum albumins. (19396020)
2009
19
Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors. (18331619)
2008
20
Comparison of prevalence of varicocele in first-degree relatives of patients with varicocele and male kidney donors. (18279919)
2008
21
Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach. (17904921)
2007
22
Comparison of five radioimmunoassay systems for PAG measurement: ability to detect early pregnancy in cows. (17635783)
2007
23
Differential regulation of the cynomolgus, human, and rat acyl-CoA oxidase promoters by PPARalpha. (16828988)
2006
24
Genotyping of five chinese patients with 17alpha-hydroxylase deficiency diagnosed through high-performance liquid chromatography serum adrenal profile: identification of two novel CYP17 mutations. (16822828)
2006
25
Reduced E-cadherin expression is an indicator of unfavourable prognosis in oral squamous cell carcinoma. (16249116)
2006
26
ZO-1 alters the plasma membrane localization and function of Cx43 in osteoblastic cells. (15855237)
2005
27
Characterization of the TGN exit signal of the human mannose 6-phosphate uncovering enzyme. (15976452)
2005
28
Surgical management of perforated duodenal ulcer: the changing scene. (15816264)
2004
29
Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts. (12748124)
2003
30
Activated eosinophils infiltrate MCF-7 breast multicellular tumor spheroids. (12680196)
2003
31
Docosahexaenoic acid membrane content and mRNA expression of acyl-CoA oxidase and of peroxisome proliferator-activated receptor-delta are modulated in Y79 retinoblastoma cells differently by low and high doses of alpha-linolenic acid. (13130515)
2003
32
Predicting survival of lung transplantation candidates with idiopathic interstitial pneumonia: does PaO(2) predict survival? (12226013)
2002
33
The decrease of IGF-I, IGF-binding protein-3 and bone alkaline phosphatase isoforms during gluten challenge correlates with small intestinal inflammation in children with coeliac disease. (11275953)
2001
34
Physical and transcriptional map of a 3-Mb region of mouse chromosome 1 containing the gene for the neural tube defect mutant loop-tail (Lp). (10051400)
1999
35
Hemoglobin F in myelodysplastic syndrome. (9619730)
1998
36
Interferon-gamma can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. (9668046)
1998
37
Metabolism in human cells of the D and L enantiomers of the carbocyclic analog of 2'-deoxyguanosine: substrate activity with deoxycytidine kinase, mitochondrial deoxyguanosine kinase, and 5'-nucleotidase. (9593124)
1998
38
Up-regulation of class II major histocompatibility complex and intercellular adhesion molecule 1 expression on scleroderma fibroblasts and endothelial cells by interferon-gamma and tumor necrosis factor alpha in the early disease stage. (9082943)
1997
39
Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. (9351976)
1997
40
Human renal-cell carcinoma tissue contains dendritic cells. (8895531)
1996
41
Association between serotonin type 2 receptor (HTR2) and bronchial asthma in humans. (8782058)
1996
42
Influence of human granulocyte-macrophage colony stimulating factor/interleukin-3 fusion protein (PIXY321) on the hematopoietic toxicity associated with anti-viral drugs (zidovudine and didanosine) in vitro using normal human marrow cells. (7475901)
1995
43
POEMS syndrome: clinical, pathological and immunological study of a case. (7708142)
1994
44
The HLA-B7Qui antigen is encoded by a new subtype of HLA-B27 (B*2708). (7974468)
1994
45
Kallmann syndrome: MR evaluation of olfactory system. (8352154)
1993
46
Retroviral-type zinc fingers and glycine-rich repeats in a protein encoded by cnjB, a Tetrahymena gene active during meiosis. (8233798)
1993
47
Arachnoid cysts of the posterior fossa. Report of three cases. (6858736)
1983
48
Massive intraperitoneal haemorrhage from a ruptured corpus luteum cyst. (14000852)
1962
49
A case of myositis ossificans progressiva. (14916211)
1952
50
Lectures on Paralysis as an Effect of Brain-Disease. (20748286)
1876

Variations for Intracranial Hypertension

About this section

Expression for genes affiliated with Intracranial Hypertension

About this section
Search GEO for disease gene expression data for Intracranial Hypertension.

Pathways for genes affiliated with Intracranial Hypertension

About this section

GO Terms for genes affiliated with Intracranial Hypertension

About this section

Biological processes related to Intracranial Hypertension according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of calcidiol 1-monooxygenase activityGO:006055910.3IL1B, TNF
2positive regulation of membrane protein ectodomain proteolysisGO:005104410.3IL1B, TNF
3sequestering of triglycerideGO:003073010.3IL1B, TNF
4regulation of establishment of endothelial barrierGO:190314010.3IL1B, TNF
5response to folic acidGO:005159310.3MTHFR, OGG1
6positive regulation of chemokine biosynthetic processGO:004508010.2IL1B, TNF
7positive regulation of fever generationGO:003162210.2IL1B, TNF
8negative regulation of lipid catabolic processGO:005099510.1IL1B, TNF
9glycerol transportGO:001579310.1AQP1, AQP4
10regulation of I-kappaB kinase/NF-kappaB signalingGO:004312210.1IL1B, TNF
11positive regulation of phagocytosisGO:00507669.9IL1B, TNF
12regulation of immunoglobulin secretionGO:00510239.7CD40LG, TNF
13leukocyte migrationGO:00509009.5F2, IL1B, TNF
14positive regulation of NF-kappaB transcription factor activityGO:00510928.7CD40LG, IL1B, TNF

Sources for Intracranial Hypertension

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet